DFCM
MDGL icon

Dark Forest Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Dark Forest Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-928
Closed -$486K – 938
2026
Q1 		$486K Buy
+928
New +$443K 0.04% 557
2025
Q4 		– Sell
-1,259
Closed -$577K – 1194
2025
Q3 		$577K Buy
+1,259
New +$470K 0.02% 890
2025
Q1 		– Sell
-1,286
Closed -$397K – 1357
2024
Q4 		$397K Buy
+1,286
New +$362K 0.06% 544
2022
Q4 		– Sell
-8
Closed -$1K – 1350
2022
Q3 		$1K Buy
+8
New +$556 ﹤0.01% 1058
2021
Q4 		– Sell
-17
Closed -$1K – 1648
2021
Q3 		$1K Buy
+17
New +$1.47K ﹤0.01% 1200

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dark Forest Capital Management's MDGL Position: Q2 2026 in Review

Dark Forest Capital Management sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2026, closing a stake of 928 shares — an estimated $486K sold.

Dark Forest Capital Management first reported a position in MDGL in Q3 2021 and held it in 5 quarters. The position peaked at $577K in Q3 2025. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Dark Forest Capital Management reported no remaining Madrigal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 928 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $486K.
  • Dark Forest Capital Management first reported a position in Madrigal Pharmaceuticals in Q3 2021 and held it in 5 quarters.
  • Dark Forest Capital Management's Madrigal Pharmaceuticals position peaked at $577K in Q3 2025.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.